Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Proteomics Research in Bypassing Surgery to Treat Type 2 Diabetes in China

NCT01870713 is registered in ClinicalTrials.gov with No. 150 Central Hospital of the Chinese People Liberation Army as lead sponsor.

NCT NCT01870713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01870713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Proteomics Research in Bypassing Surgery to Treat Type 2 Diabetes in China
Lead sponsor
No. 150 Central Hospital of the Chinese People Liberation Army
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2010
Completion date
October 31, 2013
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes